Santamaria Angelo, Corrado Francesco, Baviera Giovanni, Carlomagno Gianfranco, Unfer Vittorio, D'anna Rosario
a Department of Pediatrics, Gynecology, Microbiology and Biomedical Sciences , University of Messina , Messina , Italy and.
b A. G. Un. Co. Obstetrics and Gynecology Center , Rome , Italy.
J Matern Fetal Neonatal Med. 2016;29(14):2245-7. doi: 10.3109/14767058.2015.1081886. Epub 2015 Sep 12.
To evaluate myo-inositol concentrations in amniotic fluid in women later developing gestational diabetes and hypertension.
A retrospective study was carried out with three groups of amniotic fluid samples (15-18 gestational weeks): 30 gestational hypertension pregnancies, 30 gestational diabetes pregnancies, and 30 normal pregnancy.
A significant difference was observed in myo-inositol concentrations between the median gestational diabetes values (124.0 µmol/L, IQR 90.0-162.5) and the control group values (79.0 µmol/L, IQR 62.0-107.5), but also with gestational hypertension median values (79.0 µmol/L, IQR 67.75-92.0) (p < 0.001).
This study has shown that myo-inositol concentrations in amniotic fluid increased significantly in women later developing gestational diabetes compared to the control group.
评估日后发生妊娠期糖尿病和高血压的女性羊水肌醇浓度。
对三组羊水样本(孕15 - 18周)进行回顾性研究:30例妊娠期高血压妊娠、30例妊娠期糖尿病妊娠和30例正常妊娠。
妊娠期糖尿病组中位数(124.0 µmol/L,四分位间距90.0 - 162.5)与对照组(79.0 µmol/L,四分位间距62.0 - 107.5)的肌醇浓度存在显著差异,与妊娠期高血压组中位数(79.0 µmol/L,四分位间距67.75 - 92.0)也有显著差异(p < 0.001)。
本研究表明,与对照组相比,日后发生妊娠期糖尿病的女性羊水肌醇浓度显著升高。